Treatment.Com International Inc. (TRUE.CN)
CAD 0.41
(-1.22%)
CAD 0.41
(-1.22%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.26 CAD | 56.67% |
| 2022 | -0.60 CAD | 71.96% |
| 2021 | -2.14 CAD | -375.56% |
| 2020 | -0.45 CAD | 4.26% |
| 2019 | -0.47 CAD | -4172.73% |
| 2018 | -0.01 CAD | 27.15% |
| 2017 | -0.02 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.07 CAD | -175.0% |
| 2024 Q1 | -0.02 CAD | 82.29% |
| 2023 Q2 | -0.04 CAD | 20.8% |
| 2023 Q4 | -0.14 CAD | -16.67% |
| 2023 Q3 | -0.12 CAD | -176.5% |
| 2023 FY | - CAD | 56.67% |
| 2023 Q1 | -0.05 CAD | 57.85% |
| 2022 Q4 | -0.13 CAD | -132.97% |
| 2022 Q3 | -0.06 CAD | 38.82% |
| 2022 Q2 | -0.09 CAD | 68.55% |
| 2022 FY | - CAD | 71.96% |
| 2022 Q1 | -0.29 CAD | 67.42% |
| 2021 Q4 | -0.89 CAD | -23.61% |
| 2021 FY | - CAD | -375.56% |
| 2021 Q3 | -0.72 CAD | -105.71% |
| 2021 Q2 | -0.35 CAD | -105.88% |
| 2021 Q1 | -0.17 CAD | 15.0% |
| 2020 Q4 | -0.20 CAD | -101.82% |
| 2020 FY | - CAD | 4.26% |
| 2020 Q3 | -0.10 CAD | 17.42% |
| 2020 Q2 | -0.12 CAD | -211.69% |
| 2020 Q1 | -0.04 CAD | 90.83% |
| 2019 Q4 | -0.42 CAD | -6462.5% |
| 2019 FY | - CAD | -4172.73% |
| 2019 Q3 | -0.01 CAD | 0.0% |
| 2018 FY | - CAD | 27.15% |
| 2017 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AI/ML Innovations Inc. | -0.06 CAD | -359.364% |
| Diagnamed Holdings Corp. | -0.02 CAD | -1495.092% |
| Pangenomic Health Inc. | -0.30 CAD | 13.333% |
| nDatalyze Corp. | -0.00 CAD | -6400.0% |
| Unidoc Health Corp. | -0.04 CAD | -479.065% |